Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Aug 1;174(3):349-55.
doi: 10.1164/rccm.200604-472OC. Epub 2006 May 11.

Serial testing of health care workers for tuberculosis using interferon-gamma assay

Madhukar Pai  1 , Rajnish Joshi, Sandeep Dogra, Deepak K Mendiratta, Pratibha Narang, Shriprakash Kalantri, Arthur L Reingold, John M Colford Jr, Lee W Riley, Dick Menzies
Affiliations
Comparative Study

Serial testing of health care workers for tuberculosis using interferon-gamma assay

Madhukar Pai et al. Am J Respir Crit Care Med. .

Abstract

Rationale: Although interferon-gamma (IFN-gamma) assays are promising alternatives to the tuberculin skin test (TST), their serial testing performance is unknown.

Objective: To compare TST and IFN-gamma conversions and reversions in healthcare workers.

Methods: We prospectively followed-up 216 medical and nursing students in India who underwent baseline and repeat testing (after 18 mo) with TST and QuantiFERON-TB Gold In-Tube (QFT). TST conversions were defined as reactions greater than or equal to 10 mm, with increments of 6 or 10 mm over baseline. QFT conversions were defined as baseline IFN-gamma less than 0.35 and follow-up IFN-gamma greater than or equal to 0.35 or 0.70 IU/ml. QFT reversions were defined as baseline IFN-gamma greater than or equal to 0.35 and follow-up IFN-gamma less than 0.35 IU/ml.

Results: Of the 216 participants, 48 (22%) were TST-positive, and 38 (18%) were QFT-positive at baseline. Among 147 participants with concordant baseline negative results, TST conversions occurred in 14 (9.5%; 95% confidence interval [CI] = 5.3-15.5) using the 6 mm increment definition, and 6 (4.1%; 95% CI = 1.5-8.7) using the 10 mm increment definition. QFT conversions occurred in 17/147 participants (11.6%; 95% CI = 6.9-17.9) using the definition of IFN-gamma greater than or equal to 0.35 IU/ml, and 11/147 participants (7.5%; 95% CI = 3.8-13.0) using IFN-gamma greater than or equal to 0.70 IU/ml. Agreement between TST (10 mm increment) and QFT conversions (>or= 0.70 IU/ml) was 96% (kappa = 0.70). QFT reversions occurred in 2/28 participants (7%) with baseline concordant positive results, as compared with 7/10 participants (70%) with baseline discordant results (p < 0.001).

Conclusions: IFN-gamma assay shows promise for serial testing, but repeat results need to be interpreted carefully. To meaningfully interpret serial results, the optimal thresholds to distinguish new infections from nonspecific variations must be determined.

PubMed Disclaimer

Figures

<b>Figure 1.</b>
Figure 1.
Study flow diagram and baseline test results. TST cut-off point greater than or equal to 10 mm; QFT cut-off point IFN-γ greater than or equal to 0.35 IU/ml. QFT = QuantiFERON-TB Gold In-Tube assay; TST = tuberculin skin test.
See this image and copyright information in PMC

References

    1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009–1021. - PubMed
    1. World Health Organization. Global Tuberculosis Control. Surveillance, Planning, Financing: WHO Report 2005. Geneva: World Health Organization; 2005. pp. 1–247.
    1. Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med 1995;332:92–98. - PubMed
    1. Blumberg HM. 2004. Tuberculosis infection control in healthcare settings. In: Lautenbach E, Woeltje K, editors. Practical handbook for healthcare epidemiologists. Thorofare, NJ: Slack Incorporated. pp. 259–273.
    1. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 2005;54:1–141. - PubMed

Publication types

Substances